{"created_at":"Mon Mar 31 18:13:19 +0000 2014","id":450697363473305600,"id_str":"450697363473305600","text":"RT @Bidnessetc: $NVS has achieved a milestone in developing a treatment for the most common type of lung cancer http:\/\/t.co\/an8bv261vy","source":"web","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1874319679,"id_str":"1874319679","name":"Colleen","screen_name":"ColleenOsbaldo","location":"","url":null,"description":null,"protected":false,"followers_count":73,"friends_count":147,"listed_count":0,"created_at":"Tue Sep 17 05:51:35 +0000 2013","favourites_count":19,"utc_offset":null,"time_zone":null,"geo_enabled":false,"verified":false,"statuses_count":760,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"131516","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme14\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme14\/bg.gif","profile_background_tile":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000764801046\/5f643ae1027872b828fb5df6130099fe_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000764801046\/5f643ae1027872b828fb5df6130099fe_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/1874319679\/1386887417","profile_link_color":"009999","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"EFEFEF","profile_text_color":"333333","profile_use_background_image":true,"default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Sat Mar 29 15:43:52 +0000 2014","id":449934978764140544,"id_str":"449934978764140544","text":"$NVS has achieved a milestone in developing a treatment for the most common type of lung cancer http:\/\/t.co\/an8bv261vy","source":"\u003ca href=\"http:\/\/stocktwits.com\" rel=\"nofollow\"\u003eStockTwits Web\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1310354202,"id_str":"1310354202","name":"Bidness Etc","screen_name":"Bidnessetc","location":"St. Louis, MO","url":"http:\/\/www.bidnessetc.com\/","description":"A New Age Platform For The Latest In Finance & Everything Else","protected":false,"followers_count":17361,"friends_count":1854,"listed_count":14,"created_at":"Thu Mar 28 12:04:29 +0000 2013","favourites_count":24,"utc_offset":-25200,"time_zone":"Pacific Time (US & Canada)","geo_enabled":true,"verified":false,"statuses_count":13433,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"131516","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/378800000159687366\/4fTUz3dB.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/378800000159687366\/4fTUz3dB.jpeg","profile_background_tile":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/418344090246209536\/zaPnG2nO_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/418344090246209536\/zaPnG2nO_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/1310354202\/1389085796","profile_link_color":"009999","profile_sidebar_border_color":"000000","profile_sidebar_fill_color":"EFEFEF","profile_text_color":"333333","profile_use_background_image":true,"default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":2,"favorite_count":0,"entities":{"hashtags":[],"symbols":[{"text":"NVS","indices":[0,4]}],"urls":[{"url":"http:\/\/t.co\/an8bv261vy","expanded_url":"http:\/\/stks.co\/f0RlJ","display_url":"stks.co\/f0RlJ","indices":[96,118]}],"user_mentions":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"symbols":[{"text":"NVS","indices":[16,20]}],"urls":[{"url":"http:\/\/t.co\/an8bv261vy","expanded_url":"http:\/\/stks.co\/f0RlJ","display_url":"stks.co\/f0RlJ","indices":[112,134]}],"user_mentions":[{"screen_name":"Bidnessetc","name":"Bidness Etc","id":1310354202,"id_str":"1310354202","indices":[3,14]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Mon Mar 31 13:57:52 +0000 2014","id":450633077396475904,"id_str":"450633077396475904","text":"In case you wanted more: #FDA Advisors Think $NVS Serelaxin Could Perform Better On More Difficult Endpoints http:\/\/t.co\/UQzMiwD4kX","source":"web","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":42703163,"id_str":"42703163","name":"Sarah Karlin","screen_name":"SarahKarlin","location":"Washington, DC ","url":null,"description":"Pharmaceutical & Healthcare Reporter with @ThePinkSheet1. Formerly of @FDAnewsPharma. GW Alum, Inflexible Yogi, Distance Runner, Clown. Tweets are my own.","protected":false,"followers_count":1339,"friends_count":938,"listed_count":60,"created_at":"Tue May 26 19:50:18 +0000 2009","favourites_count":213,"utc_offset":null,"time_zone":null,"geo_enabled":false,"verified":false,"statuses_count":3480,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"709397","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme6\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme6\/bg.gif","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/3003251654\/fe0f117eaf6caec86b3bb3205cd924ce_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/3003251654\/fe0f117eaf6caec86b3bb3205cd924ce_normal.jpeg","profile_link_color":"FF3300","profile_sidebar_border_color":"86A4A6","profile_sidebar_fill_color":"A0C5C7","profile_text_color":"333333","profile_use_background_image":true,"default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"FDA","indices":[25,29]}],"symbols":[{"text":"NVS","indices":[45,49]}],"urls":[{"url":"http:\/\/t.co\/UQzMiwD4kX","expanded_url":"http:\/\/www.pharmamedtechbi.com\/publications\/the-pink-sheet\/76\/13\/fda-advisors-think-novartis-serelaxin-could-perform-better-on-more-difficult-endpoints","display_url":"pharmamedtechbi.com\/publications\/t\u2026","indices":[109,131]}],"user_mentions":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
